WASHINGTON (Reuters) - Medical device companies will come under scrutiny on Wednesday when a U.S. Senate committee probes financial payments to doctors which some say are aimed at creating loyalty for products like artificial hips and knees. The U.S. Senate Special Committee on Aging will discuss gifts, royalties and other financial enticements made to doctors and surgeons from medical device makers, and consider legislation requiring the companies to disclose the incentives on the Internet.
